The Nutraceuticals Market is expected to grow from USD 587.193 billion in 2025 to USD 859.589 billion in 2030, at a CAGR of 7.92%.
The demand for nutraceuticals (nutrition + pharmaceutical) is increasing on account of their ability to treat or prevent diseases in addition to providing nutrition. These are available in the market in the form of functional food and beverages, and herbal products like ginger, garlic, onion, turmeric, and many more. The growing aging population and growing health concerns worldwide are the major drivers driving the growth of the global nutraceuticals market. Producers term nutraceuticals for what is already available in the market in the form of food, spices, food ingredients, and dietary supplements.
• DRIVERS
o Growing health concerns
o Increasing Incidences of Chronic Diseases
• RESTRAINTS
o High cost involved
o Lack of product awareness
• INDUSTRY UPDATE
o In June 2019, Roquette Introduced PEARLITOL SW-F for Gluten-Free Nutraceuticals Dosage Forms
o In March 2019, Martin Bauer Group Acquired BI Nutraceuticals, which is expected to help the organization broaden its portfolio of ingredients.
The major players profiled in the Nutraceuticals market are Abbott Laboratories, AOR, AjinomotHealth & Nutrition North America, Inc., Archer Daniels Midland Company, Cargill, Danone S.A., Mead Johnson & Company, LLC, Nestlé, Nordic Naturals, and Omega Protein Corporation, among others.
Nutraceuticals Market Segmentation:
The Nutraceuticals market has been analyzed through the following segments: